Monday, September 28, 2026

HomeGeneral NewsWhy Foundayo, the new once-daily GLP-1 pill, is such a big deal

Why Foundayo, the new once-daily GLP-1 pill, is such a big deal

- Advertisement -


The semaglutide revolution took its next leap forward on Wednesday: The Food and Drug Administration has approved Eli Lilly’s GLP-1 oral pill for sale in the United States.

The approval for the drug, which will be sold under the brand name Foundayo, marks an important technological inflection…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed